Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Causality in Epidemiology01:21

Causality in Epidemiology

421
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
421
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Survival Tree01:19

Survival Tree

87
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
87
Determination of Expected Frequency01:08

Determination of Expected Frequency

2.2K
Suppose one wants to test independence between the two variables of a contingency table. The values in the table constitute the observed frequencies of the dataset. But how does one determine the expected frequency of the dataset? One of the important assumptions is that the two variables are independent, which means the variables do not influence each other. For independent variables, the statistical probability of any event involving both variables is calculated by multiplying the individual...
2.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

102
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
102

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated rapid cooling of high-temperature vacuum furnaces for high throughput neutron experimentation.

The Review of scientific instruments·2026
Same author

A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors.

Frontiers in oncology·2026
Same author

Ultranarrow linewidth photonic-atomic laser.

Laser & photonics reviews·2026
Same author

AB-Free Kava and Dihydromethysticin Inhibit Chronic Hexavalent Chromium Exposure-Induced Cell Malignant Transformation through Down-Regulating RNA Splicing Factor SNRPA1 Expression.

Chemical research in toxicology·2026
Same author

Bupleuri Radix ameliorates MASLD induced by high-fat diet and circadian disruption in rats: Involvement of the NR1D1-SREBF1/CYP7A1 circadian-metabolic axis.

Journal of ethnopharmacology·2026
Same author

Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancer.

NPJ breast cancer·2026

Related Experiment Video

Updated: Jul 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Estimating Potential Outcome Distributions with Collaborating Causal Networks.

Tianhui Zhou1, William E Carson2, David Carlson3

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27705, U.S.

Transactions on Machine Learning Research
|January 8, 2024
PubMed
Summary
This summary is machine-generated.

Collaborating Causal Networks (CCN) estimates full potential outcome distributions, offering deeper insights than traditional Conditional Average Treatment Effect (CATE) methods. This novel approach improves decision-making by learning comprehensive treatment effect distributions without restrictive assumptions.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

Related Experiment Videos

Last Updated: Jul 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

Area of Science:

  • Causal Inference
  • Machine Learning
  • Statistical Modeling

Background:

  • Traditional causal inference methods like CATE focus on the first moment of outcome distributions, potentially missing nuanced treatment effects.
  • Existing methods for estimating full potential outcome distributions often rely on overly simplistic or restrictive assumptions.
  • Observational studies present challenges such as sample imbalance between treatment groups.

Purpose of the Study:

  • To introduce Collaborating Causal Networks (CCN), a novel methodology for learning full potential outcome distributions.
  • To move beyond CATE estimation and provide a more comprehensive understanding of treatment effects.
  • To enable flexible, individual-specific decision-making based on learned outcome distributions and utility functions.

Main Methods:

  • Developed the Collaborating Causal Networks (CCN) framework to learn full potential outcome distributions.
  • CCN does not require restrictive assumptions on the underlying data generating process (e.g., Gaussian errors).
  • Incorporated utility functions to estimate treatment utility and accommodate individual-specific variations like risk tolerance.

Main Results:

  • CCN learns potential outcome distributions that asymptotically capture the correct distributions under standard causal inference assumptions.
  • An adjustment approach was proposed and shown to be effective in mitigating sample imbalance in observational studies.
  • CCN demonstrated improved distribution estimates compared to existing Bayesian and deep generative methods in synthetic and semi-synthetic data experiments.

Conclusions:

  • CCN offers a powerful alternative to CATE by learning full outcome distributions, leading to more comprehensive insights.
  • The framework supports flexible decision-making by incorporating individual utility functions and varying risk tolerances.
  • CCN provides improved estimation and decision-making performance over existing methods, particularly in complex observational data settings.